To our knowledge, this is the first report of genetic correction of iPSC generated from somatic cells derived from an OTCD patient and, consequently, from cells harboring a pathogenic variant in the OTC gene. This evidence concerns the gene OTC and ornithine carbamoyltransferase deficiency.